Totally disagree. CE certification has a direct impact on their ability to market, commercialise and sell the technology. Many organisations and users won't use a product without CE certification (In the EU) or equivalent elsewhere. If you think getting CE certification isn't price sensitive for a medical health technology company then you are way out of your game here.
Ann: DermaScan AI receives medical device approval, page-28
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AHI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.77M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AHI (ASX) Chart |
Day chart unavailable